Decoy Therapeutics Inc. DCOY 深 沪
等待开盘 07-03 09:30:00 美东时间
7.31
-0.310
-4.07%
华盛通- 最 高8.33
- 今 开7.26
- 成交量 7.87万股
- 最 低 7.00
- 昨 收 7.62
- 总市值 388.87万
- 52周最高 415.80
- 市盈率 静 --
- 换手率 14.80%
- 52周最低 4.3201
- 委 比 0.00%
- 总股本 53.20万
- 历史最高 533340.00
- 量 比 0.03
- 振 幅 17.45%
- 历史最低 6.1776
- 每 手 1
- 风险率 40.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股夜盘 | 707 Cayman Holdings涨62.04%，Abivax SA Sponsored ADR涨31.05%
GMEX ROBOTICS CORPORATION Class A涨-29.32%；Concentrix Corporation涨-22.83%；Decoy Therapeutics Inc.涨-16.37%
06-30 08:05
Decoy Therapeutics secures $3.5M PIPE financing; shares surge
Decoy Therapeutics (DCOY) entered into a $3.5M PIPE financing with a single healthcare-focused institutional investor. The company will use the net proceeds to advance its lead antiviral candidate int...
06-29 21:09
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket
Shares of Universe Pharmaceuticals Inc (NASDAQ:UPC) rose sharply in pre-market trading after the company announced it will acquire Best Praise International for $10.75 million. Universe Pharmaceuticals shares jumped 228.4% to $9.72 in pre-market trading. Here are some other stocks moving in pre-mark...
06-29 19:03
美股夜盘 | 大自然药业涨187.16%，Decoy Therapeutics Inc.涨20.51%
LiveWire涨-10.87%；Pyxis Tankers, Inc.涨-9.05%；Cybin, Inc.涨-8.95%
06-29 08:05
Decoy Therapeutics prices USD 3.5 million PIPE at USD 5.91 per share
Decoy Therapeutics prices USD 3.5 million PIPE at USD 5.91 per share Decoy Therapeutics priced a PIPE with one healthcare-focused institutional investor, targeting USD 3.5 million gross proceeds in an unregistered sale. Common stock or pre-funded warrants priced at USD 5.91 per share; closing expect
06-27 08:17
Decoy Therapeutics posts investor presentation on D-MAV multi-viral fusion inhibitor platform
Decoy Therapeutics posts investor presentation on D-MAV multi-viral fusion inhibitor platform Decoy Therapeutics highlighted its Designable Multi-Antivirals platform targeting viral fusion inhibition, aiming for one drug to cover multiple viruses. Presentation cited a structurally conserved target a
06-22 12:03
Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
Rick Pierce to join speakers from Boehringer Ingelheim, RA Capital and ILiAD Biotechnologies for discussion on early clinical development CAMBRIDGE, Mass., June 8, 2026 /PRNewswire/ -- Decoy...
06-08 20:00
Decoy Therapeutics Sets 2026 Annual Shareholder Meeting Date
Decoy Therapeutics ( ($DCOY) ) has issued an announcement. On May 12, 2026, Dec...
05-20 04:42
Decoy Therapeutics Q1 EPS $(4.18) Misses $(4.08) Estimate
Decoy Therapeutics (NASDAQ:DCOY) reported quarterly losses of $(4.18) per share which missed the analyst consensus estimate of $(4.08) by 2.45 percent. This is a 98.26 percent increase over losses of $(240.07) per share
05-09 06:16
